-
1
-
-
0033959521
-
Population-specific polymorphisms of the human FMO3 gene: significance for detoxication
-
Cashman J.R., Akerman B.R., Forrest S.M., and Treacy E.P. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication. Drug Metab. Dispos. 28 (2000) 169-173
-
(2000)
Drug Metab. Dispos.
, vol.28
, pp. 169-173
-
-
Cashman, J.R.1
Akerman, B.R.2
Forrest, S.M.3
Treacy, E.P.4
-
2
-
-
0036036854
-
An overview of the mechanism, substrate specificities, and structure of FMOs
-
Ziegler D.M. An overview of the mechanism, substrate specificities, and structure of FMOs. Drug Metab. Rev. 34 (2002) 503-511
-
(2002)
Drug Metab. Rev.
, vol.34
, pp. 503-511
-
-
Ziegler, D.M.1
-
3
-
-
1342309263
-
Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters
-
Hernandez D., Janmohamed A., Chandan P., Phillips I.R., and Shephard E.A. Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 14 (2004) 117-130
-
(2004)
Pharmacogenetics
, vol.14
, pp. 117-130
-
-
Hernandez, D.1
Janmohamed, A.2
Chandan, P.3
Phillips, I.R.4
Shephard, E.A.5
-
4
-
-
0026501232
-
Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver
-
Lomri N., Gu Q., and Cashman J.R. Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver. Proc. Natl. Acad. Sci. USA 89 (1992) 1685-1689
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 1685-1689
-
-
Lomri, N.1
Gu, Q.2
Cashman, J.R.3
-
5
-
-
29944437885
-
Quantitative analysis of FMO gene mRNA levels in human tissues
-
Zhang J., and Cashman J.R. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab. Dispos. 34 (2006) 19-26
-
(2006)
Drug Metab. Dispos.
, vol.34
, pp. 19-26
-
-
Zhang, J.1
Cashman, J.R.2
-
6
-
-
0030833164
-
Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans
-
Overby L.H., Carver G.C., and Philpot R.M. Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem. Biol. Interact. 106 (1997) 29-45
-
(1997)
Chem. Biol. Interact.
, vol.106
, pp. 29-45
-
-
Overby, L.H.1
Carver, G.C.2
Philpot, R.M.3
-
7
-
-
0036157094
-
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression
-
Koukouritaki S.B., Simpson P., Yeung C.K., Rettie A.E., and Hines R.N. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr. Res. 51 (2002) 236-243
-
(2002)
Pediatr. Res.
, vol.51
, pp. 236-243
-
-
Koukouritaki, S.B.1
Simpson, P.2
Yeung, C.K.3
Rettie, A.E.4
Hines, R.N.5
-
8
-
-
0042316748
-
Trimethylaminuria and a human FMO3 mutation database
-
Hernandez D., Addou S., Lee D., Orengo C., Shephard E.A., and Phillips I.R. Trimethylaminuria and a human FMO3 mutation database. Hum. Mutat. 22 (2003) 209-213
-
(2003)
Hum. Mutat.
, vol.22
, pp. 209-213
-
-
Hernandez, D.1
Addou, S.2
Lee, D.3
Orengo, C.4
Shephard, E.A.5
Phillips, I.R.6
-
9
-
-
0042383168
-
Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria
-
Zhang J., Tran Q., Lattard V., and Cashman J.R. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria. Pharmacogenetics 13 (2003) 495-500
-
(2003)
Pharmacogenetics
, vol.13
, pp. 495-500
-
-
Zhang, J.1
Tran, Q.2
Lattard, V.3
Cashman, J.R.4
-
10
-
-
28444441585
-
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development
-
Koukouritaki S.B., and Hines R.N. Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. Pharmacogenomics 6 (2005) 807-822
-
(2005)
Pharmacogenomics
, vol.6
, pp. 807-822
-
-
Koukouritaki, S.B.1
Hines, R.N.2
-
11
-
-
0035061010
-
Trimethylaminuria: the fish malodor syndrome
-
Mitchell S.C., and Smith R.L. Trimethylaminuria: the fish malodor syndrome. Drug Metab. Dispos. 29 (2001) 517-521
-
(2001)
Drug Metab. Dispos.
, vol.29
, pp. 517-521
-
-
Mitchell, S.C.1
Smith, R.L.2
-
12
-
-
0036786378
-
Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation
-
Cashman J.R., and Zhang J. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab. Dispos. 30 (2002) 1043-1052
-
(2002)
Drug Metab. Dispos.
, vol.30
, pp. 1043-1052
-
-
Cashman, J.R.1
Zhang, J.2
-
13
-
-
7144253814
-
Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication
-
Treacy E.P., Akerman B.R., Chow L.M., Youil R., Bibeau C., Lin J., Bruce A.G., Knight M., Danks D.M., Cashman J.R., and Forrest S.M. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum. Mol. Genet. 7 (1998) 839-845
-
(1998)
Hum. Mol. Genet.
, vol.7
, pp. 839-845
-
-
Treacy, E.P.1
Akerman, B.R.2
Chow, L.M.3
Youil, R.4
Bibeau, C.5
Lin, J.6
Bruce, A.G.7
Knight, M.8
Danks, D.M.9
Cashman, J.R.10
Forrest, S.M.11
-
14
-
-
0037390952
-
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria
-
Cashman J.R., Camp K., Fakharzadeh S.S., Fennessey P.V., Hines R.N., Mamer O.A., Mitchell S.C., Preti G., Schlenk D., Smith R.L., Tjoa S.S., Williams D.E., and Yannicelli S. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr. Drug Metab. 4 (2003) 151-170
-
(2003)
Curr. Drug Metab.
, vol.4
, pp. 151-170
-
-
Cashman, J.R.1
Camp, K.2
Fakharzadeh, S.S.3
Fennessey, P.V.4
Hines, R.N.5
Mamer, O.A.6
Mitchell, S.C.7
Preti, G.8
Schlenk, D.9
Smith, R.L.10
Tjoa, S.S.11
Williams, D.E.12
Yannicelli, S.13
-
15
-
-
0033582091
-
Trimethylaminuria: susceptibility of heterozygotes
-
Mitchell S.C. Trimethylaminuria: susceptibility of heterozygotes. Lancet 354 (1999) 2164-2165
-
(1999)
Lancet
, vol.354
, pp. 2164-2165
-
-
Mitchell, S.C.1
-
16
-
-
0033523477
-
Mild trimethylaminuria caused by common variants in FMO3 gene
-
Zschocke J., Kohlmueller D., Quak E., Meissner T., Hoffmann G.F., and Mayatepek E. Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet 354 (1999) 834-835
-
(1999)
Lancet
, vol.354
, pp. 834-835
-
-
Zschocke, J.1
Kohlmueller, D.2
Quak, E.3
Meissner, T.4
Hoffmann, G.F.5
Mayatepek, E.6
-
17
-
-
0030667523
-
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome
-
Dolphin C.T., Janmohamed A., Smith R.L., Shephard E.A., and Phillips I.R. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat. Genet. 17 (1997) 491-494
-
(1997)
Nat. Genet.
, vol.17
, pp. 491-494
-
-
Dolphin, C.T.1
Janmohamed, A.2
Smith, R.L.3
Shephard, E.A.4
Phillips, I.R.5
-
18
-
-
0036265797
-
Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism
-
Cashman J.R. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics 3 (2002) 325-339
-
(2002)
Pharmacogenomics
, vol.3
, pp. 325-339
-
-
Cashman, J.R.1
-
19
-
-
2942530688
-
The implications of polymorphisms in mammalian flavin-containing monoloxygenases in drug discovery and development
-
Cashman J.R. The implications of polymorphisms in mammalian flavin-containing monoloxygenases in drug discovery and development. Drug Discov. Today 9 (2004) 574-581
-
(2004)
Drug Discov. Today
, vol.9
, pp. 574-581
-
-
Cashman, J.R.1
-
20
-
-
85012859655
-
Two novel single nucleotide polymorphisms (SNPs) of the FMO3 gene in Japanese
-
Fujieda M., Yamazaki H., Togashi M., Saito T., and Kamataki T. Two novel single nucleotide polymorphisms (SNPs) of the FMO3 gene in Japanese. Drug Metab. Pharmacokinet. 18 (2003) 333-335
-
(2003)
Drug Metab. Pharmacokinet.
, vol.18
, pp. 333-335
-
-
Fujieda, M.1
Yamazaki, H.2
Togashi, M.3
Saito, T.4
Kamataki, T.5
-
21
-
-
0030803384
-
Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions
-
Brunelle A., Bi Y.A., Lin J., Russell B., Luy L., Berkman C., and Cashman J. Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions. Drug Metab. Dispos. 25 (1997) 1001-1007
-
(1997)
Drug Metab. Dispos.
, vol.25
, pp. 1001-1007
-
-
Brunelle, A.1
Bi, Y.A.2
Lin, J.3
Russell, B.4
Luy, L.5
Berkman, C.6
Cashman, J.7
-
22
-
-
1642390782
-
Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients
-
Yamazaki H., Fujieda M., Togashi M., Saito T., Preti G., Cashman J.R., and Kamataki T. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci. 74 (2004) 2739-2747
-
(2004)
Life Sci.
, vol.74
, pp. 2739-2747
-
-
Yamazaki, H.1
Fujieda, M.2
Togashi, M.3
Saito, T.4
Preti, G.5
Cashman, J.R.6
Kamataki, T.7
-
23
-
-
1642350733
-
A mutation in the flavin-containing monooxygenase 3 gene and its effects on catalytic activity for N-oxidation of trimethylaminein vitro
-
Kubota M., Nakamoto Y., Nakayama K., Ujjin P., Satarug S., Mushiroda T., Yokoi T., Funayama M., and Kamataki T. A mutation in the flavin-containing monooxygenase 3 gene and its effects on catalytic activity for N-oxidation of trimethylaminein vitro. Drug Metab. Pharmacokinet. 17 (2002) 207-213
-
(2002)
Drug Metab. Pharmacokinet.
, vol.17
, pp. 207-213
-
-
Kubota, M.1
Nakamoto, Y.2
Nakayama, K.3
Ujjin, P.4
Satarug, S.5
Mushiroda, T.6
Yokoi, T.7
Funayama, M.8
Kamataki, T.9
-
24
-
-
0029561739
-
Fish odour syndrome: verification of carrier detection test
-
Zhang A.Q., Mitchell S., and Smith R. Fish odour syndrome: verification of carrier detection test. J Inherit. Metab Dis. 18 (1995) 669-674
-
(1995)
J Inherit. Metab Dis.
, vol.18
, pp. 669-674
-
-
Zhang, A.Q.1
Mitchell, S.2
Smith, R.3
-
25
-
-
0027526217
-
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs
-
Richards B., Skoletsky J., Shuber A.P., Balfour R., Stern R.C., Dorkin H.L., Parad R.B., Witt D., and Klinger K.W. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum. Mol. Genet. 2 (1993) 159-163
-
(1993)
Hum. Mol. Genet.
, vol.2
, pp. 159-163
-
-
Richards, B.1
Skoletsky, J.2
Shuber, A.P.3
Balfour, R.4
Stern, R.C.5
Dorkin, H.L.6
Parad, R.B.7
Witt, D.8
Klinger, K.W.9
-
26
-
-
0015881843
-
A rapid micromethod for determination of FMN and FAD in mixtures
-
Faeder E.J., and Siegel L.M. A rapid micromethod for determination of FMN and FAD in mixtures. Anal. Biochem. 53 (1973) 332-336
-
(1973)
Anal. Biochem.
, vol.53
, pp. 332-336
-
-
Faeder, E.J.1
Siegel, L.M.2
-
27
-
-
0037974644
-
Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies
-
Lattard V., Zhang J., Tran Q., Furnes B., Schlenk D., and Cashman J.R. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metab. Dispos. 31 (2003) 854-860
-
(2003)
Drug Metab. Dispos.
, vol.31
, pp. 854-860
-
-
Lattard, V.1
Zhang, J.2
Tran, Q.3
Furnes, B.4
Schlenk, D.5
Cashman, J.R.6
-
28
-
-
33749021103
-
Three novel single nucleotide polymorphisms of the FMO3 gene in a Japanese population
-
Shimizu M., Fujita H., Aoyama T., and Yamazaki H. Three novel single nucleotide polymorphisms of the FMO3 gene in a Japanese population. Drug Metab. Pharmacokinet. 21 (2006) 245-247
-
(2006)
Drug Metab. Pharmacokinet.
, vol.21
, pp. 245-247
-
-
Shimizu, M.1
Fujita, H.2
Aoyama, T.3
Yamazaki, H.4
-
29
-
-
0031455166
-
Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA
-
Dolphin C.T., Riley J.H., Smith R.L., Shephard E.A., and Phillips I.R. Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA. Genomics 46 (1997) 260-267
-
(1997)
Genomics
, vol.46
, pp. 260-267
-
-
Dolphin, C.T.1
Riley, J.H.2
Smith, R.L.3
Shephard, E.A.4
Phillips, I.R.5
-
30
-
-
0027466902
-
Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains
-
Lawton M.P., and Philpot R.M. Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains. J. Biol. Chem. 268 (1993) 5728-5734
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 5728-5734
-
-
Lawton, M.P.1
Philpot, R.M.2
-
32
-
-
21244470764
-
Mild trimethylaminuria observed in a Japanese cohort with liver damage
-
Yamazaki H., Fujieda M., Cashman J.R., and Kamataki T. Mild trimethylaminuria observed in a Japanese cohort with liver damage. Am. J. Med. 118 (2005) 803-805
-
(2005)
Am. J. Med.
, vol.118
, pp. 803-805
-
-
Yamazaki, H.1
Fujieda, M.2
Cashman, J.R.3
Kamataki, T.4
-
33
-
-
23044469807
-
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants
-
Koukouritaki S.B., Poch M.T., Cabacungan E.T., McCarver D.G., and Hines R.N. Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants. Mol. Pharmacol. 68 (2005) 383-392
-
(2005)
Mol. Pharmacol.
, vol.68
, pp. 383-392
-
-
Koukouritaki, S.B.1
Poch, M.T.2
Cabacungan, E.T.3
McCarver, D.G.4
Hines, R.N.5
-
34
-
-
2442642701
-
Alternative processing events in human FMO genes
-
Lattard V., Zhang J., and Cashman J.R. Alternative processing events in human FMO genes. Mol. Pharmacol. 65 (2004) 1517-1525
-
(2004)
Mol. Pharmacol.
, vol.65
, pp. 1517-1525
-
-
Lattard, V.1
Zhang, J.2
Cashman, J.R.3
|